Scripps spin-out aTyr Pharma announced Monday that it had rounded out its patent estate covering a full suite of signaling enzymes known as Physiocrines. It's good news for aTyr, but will the IP monopoly slow the wider field down?
Gilead Sciences has started a Phase II/III trial of its novel cardiac patch worn to monitor changes in arrhythmia.
In the conference hall, attendees were lucky to have a seat at all. During breaks or at lunch, Scripps giveaway tote bags filled each seat, holding a fortunate spot for the next session's returners.
Other commercial tests only explore a small portion of the genome with gene panels - myGenome would essentially replace the need for any of those individually.
Dr. Patrick Soon-Shiong spoke today at the Future of Genomic Medicine's 9th annual conference in San Diego. The obvious focus of his presentation was the Cancer Moonshot 2020 initiative.
A brand new biotech company promising to deliver bio-superior therapeutics for several disease targets has caught the attention of investors, pulling in $9 million in its first investment round. Zebra Biologics disclosed in a SEC filing this week that it’s raised $9 million from four investors. The little information available on Zebra, which was formed […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Glooko, Inc. received an FDA nod for its Android compatible version of its next-generation diabetes management system. According to a company statement, this system is now “the only FDA-cleared mobile diabetes management system that supports the transfer of blood glucose data direct from dozens of compatible glucose meters into many Android devices.” The cloud-based management […]
There are many inspirational names in modern-day healthcare and, partially due to reform, room for even more. But a commenter on Reddit posed the question of whether there is anyone who is as well-known and charismatic a spokesperson for medicine as Neil deGrasse Tyson is for astrophysics. (Perhaps medicine is too specialized to have one […]
The push for regular interaction between patients and doctors, for mHealth and for data transparency has only begun. But the results from Scripps Translational Science Institute‘s research may add even more fuel to the flame for mHealth and patient engagement. The organization will study whether integrating wireless, medtech and social networks can bring down the […]
